Product image of Minrin Melt (Desmopressin) supplied by GNH India

Minrin Melt

Active Ingredient:
Desmopressin
Origin:
EU

Minrin Melt (Desmopressin)

Desmopressin, the active ingredient in Minrin Melt, is a vasopressin analog presented as a sublingual formulation for sublingual use. It is employed to treat central diabetes insipidus, nocturnal enuresis in children, and bleeding disorders such as mild hemophilia A and von Willebrand disease.

GNH India supplies Minrin Melt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution through reliable logistics networks and timely delivery.

Manufacturer / TM Owner

Ferring B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Desmopressin acts on the antidiuretic hormone pathway to control water balance and haemostatic function.
  • Central diabetes insipidus: reduces excessive urine output by enhancing renal water reabsorption.
  • Nocturnal enuresis: decreases nighttime bedwetting episodes in children by concentrating urine.
  • Mild hemophilia A and von Willebrand disease: raises plasma levels of factor VIII and von Willebrand factor to improve clotting.
  • Bleeding due to mild coagulation disorders: provides a temporary increase in clotting factors to support haemostasis.

How It Works

  • Desmopressin is a synthetic analogue of vasopressin that selectively binds to V2 receptors on the basolateral membrane of renal collecting‑duct cells. Activation of these receptors stimulates adenylate cyclase, increasing cyclic AMP, which promotes insertion of aquaporin‑2 water channels into the apical membrane, thereby enhancing water reabsorption. In the vascular endothelium, it stimulates release of stored factor VIII and von Willebrand factor, improving haemostatic function.

Side Effects

Desmopressin may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Hyponatremia: low blood sodium levels, often mild.
  • Headache: transient and usually mild.
  • Nausea: occasional gastrointestinal upset.
  • Abdominal cramps: mild discomfort.
  • Flushing: brief redness of the skin.

Serious or Rare Side Effects

  • Water intoxication: severe hyponatremia leading to cerebral edema.
  • Seizures: secondary to profound electrolyte disturbance.
  • Severe hyponatremia: may require urgent medical intervention.
  • Allergic reactions: rash, itching, or anaphylaxis.
  • Thromboembolic events: rare clot formation in susceptible patients.

Precautions & Warnings

  • Before initiating therapy, clinicians should consider several safety measures.
  • Renal function: assess baseline kidney status and monitor periodically.
  • Electrolytes: check serum sodium before and during treatment.
  • Fluid intake: limit excessive water consumption to reduce hyponatremia risk.
  • Concomitant drugs: avoid simultaneous use with other antidiuretics.
  • Pregnancy and lactation: use only if potential benefits outweigh risks.
  • Store at ambient temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Desmopressin can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • MAO inhibitors: increased risk of severe hyponatremia.
  • NSAIDs: may potentiate antidiuretic effect and fluid retention.
  • CYP2C9 substrates: potential alteration of drug clearance.

Moderate Interactions (Monitor Closely)

  • Antihypertensives: possible additive hypotensive effect.
  • Diuretics: may counteract desmopressin's antidiuretic action.
  • Anticoagulants: monitor clotting parameters when used together.

Frequently Asked Questions

Minrin Melt contains desmopressin and is prescribed for central diabetes insipidus, nocturnal enuresis in children, and certain bleeding disorders such as mild hemophilia A and von Willebrand disease. It helps control excessive urine output and supports clotting factor levels.

Desmopressin is a synthetic vasopressin analogue that selectively stimulates V2 receptors in the renal collecting ducts, increasing cyclic AMP and promoting insertion of aquaporin‑2 channels, which enhances water reabsorption. It also triggers release of factor VIII and von Willebrand factor from endothelial cells, aiding haemostasis.

The appropriate dose of Minrin Melt is determined by the prescribing healthcare professional based on the individual’s condition, age, weight, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for desmopressin in pregnancy and lactation are limited. It should only be used when the potential benefits justify any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Minrin Melt, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Desmopressin, the active ingredient in Minrin Melt, is more selective for V2 receptors than older antidiuretic agents like vasopressin, resulting in fewer vasoconstrictive side effects. It also has a longer duration of action and is available in convenient sublingual form, making it a preferred option for many clinicians.

Minrin Melt should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and excessive heat to maintain its stability and potency.

Minrin Melt is administered sublingually. The tablet or melt is placed under the tongue and allowed to dissolve completely without swallowing or drinking water for a few minutes, ensuring optimal absorption through the oral mucosa.

The most serious risks include severe hyponatremia leading to water intoxication, seizures, and rare allergic reactions such as anaphylaxis. Patients should be monitored for signs of low sodium, neurological changes, and any hypersensitivity symptoms.

Minrin Melt is contraindicated in patients with known hypersensitivity to desmopressin, uncontrolled hyponatremia, severe renal impairment, or those taking other potent antidiuretic agents. Clinicians should also exercise caution in individuals with a history of water‑intoxication or electrolyte disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.